Drugs / MF59 adjuvant
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT02624219 | Aug 2016 → Jan 2018 | avian influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 1 | NCT02251288 | May 2015 → Aug 2018 | avian influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 1 | NCT01317745 | May 2011 → Sep 2012 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00133471 | Mar → Dec 2005 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT03497845 | Mar 2018 → Nov 2019 | avian influenza | Biomedical Advanced Research and Development Authority | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MF59 adjuvant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02251288 ↗ |
| Known as | Microfluoridized adjuvant 59 | “Microfluoridized adjuvant 59 (MF59) is an oil-in-water emulsion.” NCT02624219 ↗ |
| Modality | Other / unclassified | “MF59 adjuvant is an oil-in-water emulsion.” NCT00133471 ↗ |
| Route | Intramuscular | “All injections will be administered in a 0.5-mL volume into the deltoid muscle.” NCT00133471 ↗ |